What Is It?
The combination of BPC-157 and TB-500 — two peptides studied in tissue-remodelling research that researchers often stack together. Named after Wolverine's regenerative abilities in X-Men. It went viral in 2026 after the FDA removed both compounds from Category 2 restrictions.
Everything in one place — $4.99/mo, cancel anytime.
How Does It Work?
Published research on BPC-157 examines blood vessel formation and intestinal biology, while research on TB-500 examines cell migration and inflammatory signaling. These are areas of investigation in tissue biology, not established outcomes in humans.
Why Researchers Stack Them
- Complementary mechanisms (angiogenesis + cell migration)
- Different tissue targets (gut/tendon + muscle/systemic)
- Both removed from FDA Category 2 restrictions (April 2026). Neither is on the FDA 503A Bulk Drug Substances List nor approved for prescription compounding; no final FDA rule has been issued.
Run the Numbers
Calculate your Wolverine Stack reconstitution — BAC water volume, syringe units, and draw amounts. Free, no login required.
Open the Calculator →The Honest Part
- No human clinical trials on the stack itself.
- Individual compounds have animal study support.
- The "Wolverine" name is marketing, not science.
- Always consult a physician before researching any compounds.
Track Wolverine Stack in the App
Peptide Manager Pro tracks 100+ compounds with an interactive knowledge graph, dosing calculator, protocol tracker, and AI research chat. Veteran-owned. $4.99/mo founding rate.
Get the App →